Basit öğe kaydını göster

dc.contributor.authorCoskun, D.
dc.contributor.authorIder, M.
dc.contributor.authorNaseri, A.
dc.contributor.authorDik, B.
dc.contributor.authorBahcivan, E.
dc.contributor.authorTras, B.
dc.contributor.authorEr, A.
dc.date.accessioned2025-03-28T07:22:51Z
dc.date.available2025-03-28T07:22:51Z
dc.date.issued2024
dc.identifier.issn1792-2720
dc.identifier.urihttps://doi.org/10.12681/jhvms.34146
dc.identifier.urihttps://hdl.handle.net/20.500.12450/5924
dc.description.abstractTilmicosin shows different degrees of cardiotoxic effect in various animal species depending on the route of administration and dose. We aimed to determine the effects of amiodarone and amiodarone+dobutamine treatments on tilmicosincardiotoxicity and survival time. 18 healthy goats were divided into tilmicosin, tilmicosin+amiodarone and tilmicosin+amiodarone+dobutamine groups. After drug administrations, the survival times of the animals in all groups were recorded. In addition, blood was drawn from the animals just before they died. Haemogram, troponin I, CK-MB, and other biochemical parameters were measured in all blood samples. Prolonged survival was observed in the treatment groups compared to the tilmicosin group. In the treatment groups, decreases in haemogram parameters, albumin, and total protein levels caused by tilmicosin could not be prevented, while the increase in troponin I level was prevented. In conclusion, while cardiotoxicity due to high troponin from tilmicosin was prevented, the survival rate was not affected in both treatment groups, and the survival time was extended at differing rates. In case of accidental or deliberate overdose of tilmicosin in animals, in addition to the use of amiodarone+dobutamine, the survival time may be prolonged, and the success may increase if the necessary symptomatic treatments and equipment support are available.en_US
dc.description.sponsorshipSUPABK [20401008]en_US
dc.description.sponsorshipWe thank Dr. EnverYazar for scientific con-tributions. This study is supported by SUPABK (20401008) .en_US
dc.language.isoengen_US
dc.publisherHellenic Veterinary Medical Socen_US
dc.relation.ispartofJournal of the Hellenic Veterinary Medical Societyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTilmicosinen_US
dc.subjectAmiodaroneen_US
dc.subjectDobutamineen_US
dc.subjectSurvival timeen_US
dc.subjectCardiotoxicityen_US
dc.titleEvaluation of the effects of amiodarone and amiodarone plus dobutamine on survival in tilmicosin-induced toxicity by electrocardiography and biochemical parameters in goatsen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume75en_US
dc.identifier.issue1en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.12681/jhvms.34146
dc.department-temp[Coskun, D.] Siirt Univ, Vet Fac, Dept Pharmacol & Toxicol, TR-56100 Siirt, Turkiye; [Ider, M.; Naseri, A.; Er, A.] Selcuk Univ, Vet Fac, Dept Internal Med, TR-42003 Konya, Turkiye; [Dik, B.; Tras, B.; Er, A.] Selcuk Univ, Vet Fac, Dept Pharmacologyand Toxicol, TR-42003 Konya, Turkiye; [Bahcivan, E.] Amasya Univ, Fac Med, Dept Med Pharmacol, TR-05100 Amasya, Turkiyeen_US
dc.identifier.wosWOS:001209307800005en_US
dc.snmzKA_WOS_20250328
dc.indekslendigikaynakWeb of Scienceen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster